HORSHAM, Pa., Sept. 1 /PRNewswire/ -- World-renowned golf champion and prostate cancer survivor Arnold Palmer has teamed up with Centocor Ortho Biotech Inc. and the non-profit organization Us TOO International Prostate Cancer Education & Support Network to launch My Prostate Cancer Roadmap (www.myprostatecancerroadmap.com), an educational program that provides resources and information specific to advanced prostate cancer patients and those who love them. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/myprostatecancerroadmap/45323/ (Photo: http://photos.prnewswire.com/prnh/20100901/MM55024) (Photo: http://www.newscom.com/cgi-bin/prnh/20100901/MM55024) Every year, approxi...
Prostate Cancer Non-Profit Recognized for 20 Years of Service
CHICAGO, Aug. 18 /PRNewswire-USNewswire/ -- The prostate cancer community joins together in congratulating Us TOO International Prostate Cancer Education & Support Network (www.ustoo.org) in their 20th anniversary of continued prostate cancer support, education and advocacy.
(Logo: http://photos.prnewswire.com/prnh/20100604/DC16079LOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20100604/DC16079LOGO)
The grassroots organization was founded in 1990 by a group of prostate cancer survivors on a mission to help not just other prostate cancer patients – but also their families and loved ones being impacted by the disease.
American Cancer Society Got it Wrong: Study Confirms Prostate Cancer Test Saves Lives
ZERO Demands ACS Apology to All American Families About Prostate Cancer Testing as New Proof Emerges on the Effectiveness of the PSA Test
WASHINGTON, July 2 /PRNewswire-USNewswire/ -- With a new study showing the PSA test reduces the prostate cancer death rate by 44 percent, ZERO – The Project to End Prostate Cancer demands an apology for all at risk of the disease from the American Cancer Society, which has long discounted the importance of prostate cancer testing.
"It's time to 'Man Up' and admit they were wrong," said ZERO CEO Skip Lockwood.